ADVENTRX Pharmaceuticals, Inc. (ANX) - Financial and Strategic SWOT Analysis Review

GlobalData, March 2012, Pages: 37

ADVENTRX Pharmaceuticals, Inc. (ANX) - Financial and Strategic SWOT Analysis Review

Summary

ADVENTRX Pharmaceuticals, Inc. (Adventrx) is a biopharmaceutical company, involved in the acquisition, development and commercialization of pharmaceuticals in the areas of hematology and oncology. The company operates its business in a single reportable segment which is development of proprietary drug candidates. The product pipeline of the company includes ANX-188 which is an aqueous solution of purified form of poloxamer 188 for the treatment of sickle cell disease indications; ANX-154 which is an emulsion formulation of docetaxel to treat solid tumors; and Exelbine which is a novel emulsion formulation of the chemotherapy drug vinorelbine. The company operates through its two subsidiaries, namely, SD Pharmaceuticals, Inc., SynthRx, Inc. and ADVENTRX (Europe) Ltd. The company is headquartered in San Diego, California, the US

The company aims at the successful discovery, development and marketing of its proprietary product candidates focused on huge-demand market of oncology and hematology. This intent can be reflected from the recent review discussions with the US Food and Drug Development (FDA) for optimal development programs with respect to its product candidates ANX-514 and ANX-188 as well as the public offering of its common shares in order to finance the clinical programs.

ADVENTRX Pharmaceuticals, Inc. Key Recent Developments

Mar 07, 2012: ADVENTRX Pharmaceuticals Reports Q4 2011 Results
Nov 07, 2011: ADVENTRX Pharmaceuticals Reports Q3 2011 Results
Oct 19, 2011: ADVENTRX Pharmaceuticals To Present At 10TH Annual BIO Investor Forum
Aug 08, 2011: ADVENTRX Pharmaceuticals Reports Q2 2011 Results
Jul 25, 2011: ADVENTRX Appoints Gregory Gorgas As Senior Vice President, Commercial

This comprehensive SWOT profile of ADVENTRX Pharmaceuticals, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
ADVENTRX Pharmaceuticals, Inc. - Key Facts
ADVENTRX Pharmaceuticals, Inc. - Key Employees
ADVENTRX Pharmaceuticals, Inc. - Key Employee Biographies
ADVENTRX Pharmaceuticals, Inc. - Major Products and Services
ADVENTRX Pharmaceuticals, Inc. - Pharmaceutical Pipeline Products Data
ADVENTRX Pharmaceuticals, Inc., Pipeline Products by Therapy Area
ADVENTRX Pharmaceuticals, Inc., Pipeline Products by Development Phase
ADVENTRX Pharmaceuticals, Inc. - History
ADVENTRX Pharmaceuticals, Inc. - Company Statement
ADVENTRX Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
ADVENTRX Pharmaceuticals, Inc. - Business Description
ADVENTRX Pharmaceuticals, Inc. - Corporate Strategy
ADVENTRX Pharmaceuticals, Inc. - SWOT Analysis
SWOT Analysis - Overview
ADVENTRX Pharmaceuticals, Inc. - Strengths
Strength - Sturdy R&D Activities
Strength - Strong Patent Portfolio
Strength - Strong Liquidity Position
ADVENTRX Pharmaceuticals, Inc. - Weaknesses
Weakness - Lack of Product Based Revenues
ADVENTRX Pharmaceuticals, Inc. - Opportunities
Opportunity - Market Opportunities - Oncology
Opportunity - Changing Demographies
Opportunity - Inorganic Growth Strategies
ADVENTRX Pharmaceuticals, Inc. - Threats
Threat - Stringent Government Regulations
Threat - Competitive Pressures
Threat - Uncertain R&D Outcomes
Threat - Dependence on Third Party Manufacturing
ADVENTRX Pharmaceuticals, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ADVENTRX Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
ADVENTRX Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
ADVENTRX Pharmaceuticals, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
ADVENTRX Pharmaceuticals, Inc., Recent Developments
Mar 07, 2012: ADVENTRX Pharmaceuticals Reports Q4 2011 Results
Nov 07, 2011: ADVENTRX Pharmaceuticals Reports Q3 2011 Results
Oct 19, 2011: ADVENTRX Pharmaceuticals To Present At 10TH Annual BIO Investor Forum
Aug 08, 2011: ADVENTRX Pharmaceuticals Reports Q2 2011 Results
Jul 25, 2011: ADVENTRX Appoints Gregory Gorgas As Senior Vice President, Commercial
May 09, 2011: ADVENTRX Pharmaceuticals Reports Net Loss Of $3m For Q1 2011
Mar 10, 2011: ADVENTRX Reports Net Loss Of $2.3m For Q4 2010
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ADVENTRX Pharmaceuticals, Inc., Key Facts
ADVENTRX Pharmaceuticals, Inc., Key Employees
ADVENTRX Pharmaceuticals, Inc., Key Employee Biographies
ADVENTRX Pharmaceuticals, Inc., Major Products and Services
ADVENTRX Pharmaceuticals, Inc., Number of Pipeline Products by Therapy Area
ADVENTRX Pharmaceuticals, Inc., Number of Pipeline Products by Development Stage
ADVENTRX Pharmaceuticals, Inc., Pipeline Products By Therapy Area and Development Phase
ADVENTRX Pharmaceuticals, Inc., History
ADVENTRX Pharmaceuticals, Inc., Subsidiaries
ADVENTRX Pharmaceuticals, Inc., Key Competitors
ADVENTRX Pharmaceuticals, Inc., Ratios based on current share price
ADVENTRX Pharmaceuticals, Inc., Annual Ratios
ADVENTRX Pharmaceuticals, Inc., Interim Ratios
ADVENTRX Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
ADVENTRX Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
ADVENTRX Pharmaceuticals, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
ADVENTRX Pharmaceuticals, Inc., Pipeline Products by Therapy Area
ADVENTRX Pharmaceuticals, Inc., Pipeline Products by Development Phase
ADVENTRX Pharmaceuticals, Inc., Performance Chart (2007 - 2011)
ADVENTRX Pharmaceuticals, Inc., Ratio Charts
ADVENTRX Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
ADVENTRX Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Scientific Games Corporation - Company Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• eBay - Strong Execution
• Amazon - Point of Realization in 2013?
• Ixia - Company Analysis
• SunGard - Profile - US
• Insight into Samsung Electronics' Notebook PC Business Model
• US - Accenture - Company Profile